Dr TR Leyshon Griffiths

I qualified from St. Bartholomew's Hospital Medical School in London in 1989. After early posts at Cambridge (Downing College), London and Norwich, I obtained a research MD in Newcastle and won the national Patey Prize from the Surgical Research Society for my work on 'Role of P53 in Bladder Cancer'. I completed Urological surgical training in Newcastle and was appointed to my current post as Consultant Urological Surgeon in Leicester in 2002. At Leicester Medical School, I have a teaching-focused post where I am Head of Year 4, Professionalism Support Unit Lead and Academic Champion for Undergraduate Medical Education. I am a member of the UK Council for Teachers of Professionalism.

I have a special clinical interest in hyperthermic intravesical chemotherapy (HIVEC) for BCG-unresponsive, high risk, non-muscle invasive bladder cancer.  I also have a research interest in patient safety - 'Developing Healthcare Team Observations for Patient Safety (HTOPS).

Development and validation of a marketable Healthcare Normal Operations Safety Audit patient safety education and in loco risk-management tool
- Funded by Wellcome Trust Institutional Support Fund Translation and Innovation Scheme
Co-leads on this project are Professor Liz Anderson (University of Leicester), Professor Bob Norman (University of Leicester), Professor George Martin (University of Cambridge) and Teri Forey (Software Engineer collaborator)

Developing Healthcare Team Observations for Patient Safety (HTOPS):  senior medical students capture everyday moments.
E.S. Anderson, TRL Griffiths, T Forey, F Wobi, RI Norman, G Martin.  Pilot Feasibility Studies, 2021 Aug 23; 7(1):164.  PMID: 34425912

Major Urological Cancer Surgery for patients is safe and surgical raining should be encouraged during the COVID-19 pandemic. A multicentre analysis of 30-day outcomes. 
Tan WS, Arianayagam R, Khetrapal P, Rowe E, Kearley S, Mahrous A, Pal R, Fowler W, Heer R, Elajnaf M, Douglas-Moore J, Leyshon Griffiths TR, Voss J, Wilby D, Al Kadhi O, Noel J, Vasdev N, McKay A, Ahmad I, Abu-Nayla I, Lamb B, Hill GT, Narahari K, Kynaston H, Yousuf A, Kusuma VRM, Cresswell J, Cooke P, Chakravarti A, Barod R, Bex A, Kelly JD; a multicentre collaborator group.  Eur Urol Open Sci. 2021 Mar;25:39-43. PMID: 33458711 

CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancer.
Mostafid AH, Porta N, Cresswell J, Griffiths TRL, Kelly JD, Penegar SR, Davenport K, McGrath JS, Campain N, Cooke P, Masood S, Knowles MA, Feber A, Knight A, Catto JWF, Lewis R, Hall E.BJU In 2020 Jun;125(6):817-826. PMID: 32124514

Surgeon-Team Separation in Robotic Theaters:  A Quantitative Observational and Interview Study.  
Dina El-Hamamsy, Thomas J Walton, TR Leyshon Griffiths, Elizabeth S Anderson, Douglas G Tincello.  Female Pelvic Med Reconstr Surg Feb 2020; 26(2): 86-91.  PMID:  31990793 

Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guerin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial.  
Tan WS, Panchal A, Buckley L, Devall AJ, Loubiere LS, Pope AM, Feneley MR, Cresswell J, Issa R, Mostafid H, Madaan S, Bhatt R, McGrath J, Sangar V, Griffiths TRL, Page T, Hodgson D, Datta SN, Billingham LJ, Kelly JD.  Eur Urol. 2019 Jan;75(1):63-71.  PMID: 30274699 

Renal Tumour Biopsy--A New Standard of Care?
Kockelbergh R, Griffiths L.Eur Urol. 2016 Apr;69(4):674-675. PMID: 26427565 

Is Immediate Radical Cystectomy Necessary for All Patients with Non-Muscle-Invasive Micropapillary Bladder Cancer?  
Jackson BL, Mohammed A, Mayer N, Dormer J, Griffiths TR.  Urol Int. 2016;96(1):32-8.  PMID: 25924623

Current perspectives in bladder cancer management.  
Griffiths TR; Action on Bladder Cancer.  Int J Clin Pract, 2013 May;67(5):435-48.  PMID 23137019

Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: Systematic review and meta-analysis.
Mowatt G, N'Dow J, Vale L, Nabi G, Boachie C, Cook JA, Fraser C, Griffiths TR; Aberdeen Technology Assessment Review (TAR) Group.  Int J Technol Assess Health Care. 2011 Jan;27(1):3-10.  PMID: 21262078

Treatment of carcinoma in situ with intravesical bacillus Calmette-Guerin without maintenance.
Griffiths TR, Charlton M, Neal DE, Powell PH.  J Urol. 2002 Jun;167(6):2408-12.  PMID: 11992047

Personal Tutor to Phase 1 students

Clinical Supervisor

Educational Supervisor

Academic Champion for Undergraduate Medical Education

 

1. Undergraduate medical course
2. MSc Cancer Molecular Pathology and Therapeutics Course

My key teaching interests are 1) Patient Safety 2) Leadership 3) Professionalism 4) Men's Health 5) Urological malignancies

Bladder cancer

Member of UK Council for Teachers of Medical Professionalism
Member of British Association of Urological Surgeons
Member of European Association of Urology

BSc MBBS MD FRCSEd (Urol) SFHEA